Articles
Title: Transcient cardiac enlargement: an unusual adverse event associated with growth hormone therapy
- Author:
- Urszula Oczkowska
- Type:
- Case Reports
- Language:
- PL
- Journal:
- Pediatric Endocrinology, Diabetes and Metabolism
- Year:
- 2001
- Volume:
- 7
- Number:
- 1
- Start page:
- 53
- Final page:
- 56
- ISSN:
- 2081-237X
- Keywords:
- growth hormone deficiency, growth hormone therapy, adverse events
Read A 7-year old boy who developed transcient oedemas and cardiac enlargement during the first month of the
growth hormone therapy in a dose of 0.7 U/kg/week is described. These symptoms resolved rapidly with
the dose reduction. No further adverse events were observed.